InSilico Medicine Cayman TopCo (IMDCY)

Market Cap	2.79B
Revenue (ttm)	135.09M +152.0%
Net Income	-297.56M
EPS	-1.81
Shares Out	n/a
PE Ratio	n/a
Forward PE	36.11
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100
Open	9.87
Previous Close	10.06
Day's Range	9.87 - 9.87
52-Week Range	9.42 - 17.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About IMDCY

InSilico Medicine Cayman TopCo engages in applying artificial intelligence (AI) solutions to drug discovery and development by leveraging its proprietary platforms. The company offers Pharma.AI, an AI-powered drug discovery and development platform offering new target identification, small molecule generation, and clinical outcome prediction services. Its pipeline covers solutions for fibrosis, oncology, immunology, metabolic, anti-pain, and other therapeutic areas. The company is also involved in research and development collaboration, softwar...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2014
• Employees: 333
• Stock Exchange: OTCMKTS
• Ticker Symbol: IMDCY

Financial Performance

In 2025, IMDCY's revenue was $56.24 million, a decrease of -34.48% compared to the previous year's $85.83 million. Losses were -$352.32 million, 1960.8% more than in 2024.

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Nov 9, 2026

Data Sources Report a data error